Moomoo AIのまとめ
MEDIROM Healthcare Technologies has entered into a Second Unsecured Convertible-Type Corporate Bonds agreement with Triple One Investment Partnership for JPY 300 million, due October 29, 2027. The bonds will carry a 2% annual interest rate, payable semiannually starting June 30, 2025. The conversion price is set at JPY 957 per common share, based on the weighted average price of the company's ADSs over six months prior to September 30, 2024.The proceeds will primarily fund investments in the Digital Preventative Healthcare Segment, focusing on enhancing MOTHER Bracelet® functionality through algorithm development, expanding health data capabilities, improving REMONY® software, and increasing product inventory. The bonds will be issued outside the United States under Regulation S of the Securities Act.The bonds will be issued in JPY 100 million denominations, with the closing date scheduled for October 25, 2024. The Bond Holder may convert the bonds into common shares at any time until maturity, while transfers require board approval. Early repayment is restricted except with mutual agreement between the company and Bond Holder.
MEDIROM Healthcare Technologies has entered into a Second Unsecured Convertible-Type Corporate Bonds agreement with Triple One Investment Partnership for JPY 300 million, due October 29, 2027. The bonds will carry a 2% annual interest rate, payable semiannually starting June 30, 2025. The conversion price is set at JPY 957 per common share, based on the weighted average price of the company's ADSs over six months prior to September 30, 2024.The proceeds will primarily fund investments in the Digital Preventative Healthcare Segment, focusing on enhancing MOTHER Bracelet® functionality through algorithm development, expanding health data capabilities, improving REMONY® software, and increasing product inventory. The bonds will be issued outside the United States under Regulation S of the Securities Act.The bonds will be issued in JPY 100 million denominations, with the closing date scheduled for October 25, 2024. The Bond Holder may convert the bonds into common shares at any time until maturity, while transfers require board approval. Early repayment is restricted except with mutual agreement between the company and Bond Holder.
MEDIROm Healthcare Technologiesは、Triple One Investment Partnershipと共に、2027年10月29日満期の30000万円の第二次無担保転換型社債契約を締結しました。この債券は年利2%の金利が適用され、2025年6月30日から半期ごとに支払われます。転換価格は2024年9月30日の6か月前における同社のADSの加重平均価格を基に、1株あたり957円に設定されています。調達資金は、アルゴリズム開発を通じたMOTHER Bracelet®の機能向上、健康データ能力の拡充、REMONY®ソフトウェアの改善、および製品在庫の増加に焦点を当てた...すべて展開
MEDIROm Healthcare Technologiesは、Triple One Investment Partnershipと共に、2027年10月29日満期の30000万円の第二次無担保転換型社債契約を締結しました。この債券は年利2%の金利が適用され、2025年6月30日から半期ごとに支払われます。転換価格は2024年9月30日の6か月前における同社のADSの加重平均価格を基に、1株あたり957円に設定されています。調達資金は、アルゴリズム開発を通じたMOTHER Bracelet®の機能向上、健康データ能力の拡充、REMONY®ソフトウェアの改善、および製品在庫の増加に焦点を当てたデジタル予防医療部門への投資に主に使用されます。この債券は、米国の証券法の規制Sの下で発行されます。債券は10000万円の単位で発行され、締結日は2024年10月25日に予定されています。債券保有者は満期までいつでも債券を普通株に転換できますが、譲渡には取締役会の承認が必要です。早期返済は、会社と債券保有者との相互合意がない限り制限されています。
役に立った
役に立たない
